88
Participants
Start Date
April 27, 2012
Primary Completion Date
May 19, 2015
Study Completion Date
May 15, 2018
Azacitidine
Azacitidine at 75 mg/m\^2/day subcutaneous on Days 1-7
Lenalidomide
Lenalidomide 50 mg PO daily x 28 days for the first 2 cycles then 25 mg PO daily x 28 days for the next 2 cycles followed by continuous 28-day cycles of lenalidomide 10 mg PO daily
Best Supportive Care (BSC)
"The use of BSC was considered as concomitant treatment and must be documented as concomitant medication.~BSC includes, but is not limited to, treatment with Red Blood Celll (RBC) or whole blood transfusions, fresh frozen plasma transfusions, platelet transfusions, antibiotic or antifungal therapy, and nutritional support"
(205) Greenville Hospital System, Greenville
(145) Mount Sinai Comprehensive Cancer Center, Miami Beach
(230) Tennessee Oncology, PLLC, Nashville
(175) University Lousiville, Louisville
(135) University of Wisconsin, Madison
(235) University of Minnesota, Minneapolis
(120) Avera Cancer Institute, Sioux Falls
(150) Billings Clinic, Billings
(140) Rush University Medical Center, Chicago
(185) The University of Kansas Cancer Center, Westwood
(195) Tulane University Hospital Tulane Cancer Center, New Orleans
(155) Cancer Care Centers of South Texas, San Antonio
(115) University of Colorado Anschultz Cancer Center, Aurora
(210) University of Arizona Cancer Center, Tucson
(240) Cedars-Sinai Medical Center, Los Angeles
(215) Hematology Oncology Medical Group, Orange
(200) Coastal Integrative Cancer Care, San Luis Obispo
(125) University of Stanford, Stanford
(130) UC Davis Medical Center, Sacramento
(180) University of California, San Diego, La Jolla
(100) Washington University School of Medicine, St Louis
(165) Mount Sinai Medical Center New York, New York
(160) The Western Pennsylvania Hospital- Cancer Institute, Pittsburgh
(105) University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center, Dallas
(402) Tom Baker Cancer Centre, Calgary
(405) University of Alberta Hospital, Edmonton
(401) Cancer Care Manitoba, Winnipeg
(403) Queen Elizabeth II Health Sciences Centre - VG Site, Halifax
(404) The Ottawa Hospital, Ottawa
(400) Princess Margaret Hospital, Toronto
Lead Sponsor
Celgene
INDUSTRY